ArticlePhysics and imaging in radiation oncology2026
Helium pencil beam commissioning and beam modeling.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: Helium ions combine reduced lateral scattering compared to protons and a lower fragmentation tail than carbon ions, enabling sharp dose gradients and improved normal tissue sparing. This study reports the commissioning of a scanned helium pencil beam line and validation of its corresponding beam model. Materials and Methods: Synchrotron-based helium ion beams were commissioned covering energies from 54.6 to 402.8 MeV/u. Depth-dose curves were measured and absolute dose calibration was performed. Beam optics (spot size, position, and intraspill stability) were evaluated for various spill lengths. A beam model was implemented in the RayStation treatment planning system (TPS) and validated through 2D absolute dose measurements in homogeneous and heterogeneous phantoms and 3D measurements of cubic spread-out Bragg peak fields. Gamma-index analysis and Monte Carlo (MC) simulations with GATE/Geant4 were performed for benchmarking. Results: Measured ranges agreed with MC simulations within Conclusions: Stable scanned beam delivery with helium ions was established. Validation demonstrated strong agreement between measurements, TPS calculations, and MC simulations, supporting research and future clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.